HIV/AIDS in the Post-HAART Era: Manifestations, Treatment, Epidemiology

Acquir Immune acquired immunodeficiency syndrome active antiretroviral therapy African Americans agents AIDS-related amphotericin antibody antiretroviral therapy antiviral assay associated biopsy candidiasis CD4 counts cells/mm3 CHAPTER chronic Clin Infect cohort coinfected common condom cutaneous cytomegalovirus Dermatol detection diagnosis disease efavirenz effective Engl epidemic fluconazole ganciclovir HAART HALL & COCKERELL hepatitis herpes simplex highly active antiretroviral HIV infection HIV prevention HIV transmission HIV-associated HIV-infected patients HIV-positive patients HIV/AIDS human immunodeficiency virus human papillomavirus Immune Defic Syndr immune reconstitution inflammatory immunodeficiency virus type incidence increased individuals inhibitors initiation interventions IRIS itraconazole Kaposi’s sarcoma Lancet Latino lesions lymphoma occur opportunistic infections oral patients with AIDS plasma Pneumocystis pneumonia population POST-HAART prevalence prophylaxis protein pulmonary rates reconstitution inflammatory syndrome regimens reported resistance response retinitis risk behaviors risk factors sex workers sexual symptoms tenofovir testing tion treatment tuberculosis ulcer vaccine viral load women zidovudine